SSG
CELG

Summit Securities Group’s Celgene Corp CELG Stock Holding History

Summit Securities Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-168
Closed -$1.67M – 564
2019
Q3 		$1.67M Sell
168
-496
-75% -$47.1K 0.15% 102
2019
Q2 		$6.14M Sell
664
-5,276
-89% -$501K 0.71% 27
2019
Q1 		$56M Buy
5,940
+2,719
+84% +$238K 10.23% 2
2018
Q4 		$20.6M Buy
3,221
+2,627
+442% +$194K 1.79% 8
2018
Q3 		$3K Sell
594
-472
-44% -$41.7K ﹤0.01% 185
2018
Q2 		$8.47M Sell
1,066
-882
-45% -$73.2K 1.22% 15
2018
Q1 		$17.4M Buy
+1,948
New +$187K 4.25% 3

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Summit Securities Group's CELG Position: Q4 2019 in Review

Summit Securities Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 32,949 shares — an estimated $3.27M sold.

Summit Securities Group first reported a position in CELG in Q2 2016 and held it in 4 quarters. The position peaked at $3.27M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Summit Securities Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Summit Securities Group sold 32,949 Celgene Corp shares in Q4 2019, an estimated $3.27M.
  • Summit Securities Group first reported a position in Celgene Corp in Q2 2016 and held it in 4 quarters.
  • Summit Securities Group's Celgene Corp position peaked at $3.27M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Summit Securities Group's 13F filing for Q4 2019, filed 13 Jan 2020.